Summary of 2025 AHA/ACC Hypertension Guidelines in brief. Here we present just a brief of the hypertension guidelines
BP Categories
– Normal: <120/<80 mmHg
– Elevated: 120-129/<80 mmHg
– Stage 1: 130-139 or 80-89 mmHg
– Stage 2: ≥140 or ≥90 mmHg
Table Categories of Blood Pressure in Adults*
| SBP | DBP | ||
|---|---|---|---|
| BP Category | |||
| Normal | <120 mm Hg | and | <80 mm Hg |
| Elevated | 120 to 129 mm Hg | and | <80 mm Hg |
| Hypertension | |||
| Stage 1 | 130 to 139 mm Hg | or | 80 to 89 mm Hg |
| Stage 2 | ≥140 mm Hg | or | ≥90 mm Hg |
Lifestyle Modification (First-line for all)
1. DASH diet
2. ↓ Na (sodium reduction)
3. ↑ K (potassium increase, unless CKD)
4. Weight management
5. Moderate activity
6. Stress control
7. Limit alcohol
When to Start Medications
– Always if BP ≥140/90 mmHgIf BP ≥130/80 mmHg with:
1. CVD
2. Stroke
3. DM (diabetes mellitus)
4. CKD (chronic kidney disease)
5. 10-year CVD risk ≥7.5% (using PREVENT calculator)
– If risk <7.5%: start meds after 3-6 months lifestyle trial if BP still ≥130/80 mmHg
Preferred Therapy
– Stage 2 HTN: 2 first-line drugs in a single-pill combo to improve adherence & speed control.
Special Considerations
– Pregnancy:
Treat ≥160/110 mmHg urgently; target <140/90 for chronic HTN; avoid certain medications (ACEI, ARB, etc.); consider low-dose aspirin to ↓ preeclampsia risk.
– Resistant HTN:
Screen for secondary cause (Primary aldosteronism); multidisciplinary eval before considering renal denervation.
– Severe HTN (>180/120) w/o acute organ damage:
Manage outpatient; no rapid IV/PO BP lowering unless organ injury is present.
– Primary goal for prevention of CVD, stroke, dementia, CKD, and mortality: BP <130/80 mmHg for all adults.
TOP TAKE-HOME MESSAGES for High Blood pressure
1. High blood pressure is the most prevalent and modifiable risk factor for the development of cardiovascular diseases, including coronary artery disease, heart failure, atrial fibrillation, stroke, dementia, chronic kidney disease, and all-cause mortality. The overarching blood pressure treatment goal is <130/80 mm Hg for all adults, with additional considerations for those who require institutional care, have a limited predicted lifespan, or are pregnant.
2. Clinicians should collaborate with community leaders, health systems, and practices to implement screening of all adults in their communities and implement guideline-based recommendations regarding prevention and management of high blood pressure to improve rates of blood pressure control.
3 . Multidisciplinary team-based care is effective in assessing and addressing patient access to medications and other structural barriers to support individual patient needs and thereby reduce barriers to achieving hypertension control. Team members may include physicians, pharmacists, nurse practitioners, nurses, physician assistants/associates, dieticians, community health workers, and other health care professionals.
4.Blood pressure is classified by the following framework: normal blood pressure is defined as <120 mm Hg systolic and <80 mm Hg diastolic; elevated blood pressure as 120 to 129 mm Hg systolic and <80 mm Hg diastolic; stage 1 hypertension as 130 to 139 mm Hg systolic or 80 to 89 mm Hg diastolic; and stage 2 hypertension as ≥140 mm Hg systolic or ≥90 mm Hg diastolic.
5. For all adults, lifestyle changes, including maintaining or achieving a healthy weight, following a heart-healthy eating pattern (such as DASH [Dietary Approaches to Stop Hypertension]), reducing sodium intake, increasing dietary potassium intake, adopting a moderate physical activity program, managing stress, and reducing or eliminating alcohol intake are strongly recommended to prevent or treat elevated blood pressure and hypertension.
6 . Initiation of medication therapy to lower blood pressure in addition to lifestyle interventions is recommended for all adults with average blood pressure ≥140/90 mm Hg and/or for selected adults with average blood pressure ≥130/80 mm Hg who have clinical cardiovascular disease, previous stroke, diabetes, chronic kidney disease, or increased 10-year predicted cardiovascular risk of ≥7.5% defined by PREVENT™ (Predicting Risk of CVD EVENTs).
7. In adults with average blood pressure ≥130/80 mm Hg and over 10-year cardiovascular disease risk defined by PREVENT of <7.5%, initiation of medication therapy to lower blood pressure is recommended if average blood pressure remains ≥130/80 mm Hg after an initial 3- to 6-month trial of lifestyle modification.
8. For all adults with stage 2 hypertension, the initiation of antihypertensive drug therapy with 2 first-line agents of different classes in a single-pill, fixed-dose combination is preferred over 2 separate pills to improve adherence and reduce time to achieve blood pressure control.
9. Home blood pressure monitoring combined with frequent interactions with multidisciplinary team members using standardized measurement and treatment protocols and home measurement protocols is an important integrated tool to improve rates of blood pressure control. Reliance on cuffless devices, including smartwatches, for accurate blood pressure measurements should be avoided until these devices demonstrate greater precision and reliability.
10. Severe hypertension in nonpregnant individuals, defined as blood pressure >180/120 mm Hg, without evidence of acute target organ damage, should be evaluated and treated in the outpatient setting with initiation, reinstitution, or intensification of oral antihypertensive medications promptly.
2025 AHA/ACC Hypertension Guideline Download PDf